Antibiotic resistance is a growing issue that physicians and medical professionals worldwide cite as cause for concern. Researchers found that two protein families provide aid in processes that allow various bacteria to grow and survive.
Targeting these proteins is what could lead to the development of a new class of antibiotics that can fight a wider swath of pathogens, “including those that cause some of the world’s deadliest diseases, such as cholera,” according to a Feb. 16 press release.